Statistics for Biogen (id:7102 BIIB)

Valuation metrics

Market cap

23.01B

Enterprise value

28.27B

Trailing P/E (ttm)

14.28

Forward P/E

9.48

PEG ratio

9.48

Price/Sales (ttm)

2.40

Price/Book (mrq)

1.41

Enterprise Value/Revenue

2.94

Enterprise Value/EBITDA

9.80

Overview

Shares outstanding

145.72M

Float

145.18M

Shares short

3.12M

% Held by insiders

0.00%

% Held by institutions

0.93%

Average volume (10 days)

1.81M

Average volume (90 days)

Price summary

52-Week low

153.62

52-Week high

268.30

52-Week change

-48.69%

Beta

-0.06

50-Day moving average

185.99

200-Day moving average

209.94

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

January 18th, 2001

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

16.81%

Operating margin

20.74%

Operational effectiveness

Return on assets

4.99%

Return on equity

10.47%

Income statement

Revenue (ttm)

66.12

Revenue per share (ttm)

66.12

Quarterly revenue growth (yoy)

Gross profit (ttm)

7.30B

EBITDA

2.93B

Net income to common (ttm)

1.62B

Diluted EPS (ttm)

11.06

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

1.70B

Total cash per share (mrq)

11.66

Total debt (mrq)

6.65B

Total Debt/Equity (mrq)

40.66

Current ratio (mrq)

125.90%

Book value per share (mrq)

112.28

Cash flow

Cash flow statement

2.13B

Levered free cash flow (LFCF)

2.03B